Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter, randomized, open-labeled, positive controlled phase 2\&3 combined study to evaluate the safety and efficacy of weekly Y-shape pegylated somatropin, compared to daily somatropin (Norditropin®), in prepubertal, treatment-naive children with growth hormone deficiency.
Epistemonikos ID: 5387d96c1795f08c020548d4b02482d1241ab8ba
First added on: May 07, 2024